1. Home
  2. NPV vs CINGW Comparison

NPV vs CINGW Comparison

Compare NPV & CINGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NPV
  • CINGW
  • Stock Information
  • Founded
  • NPV 1993
  • CINGW N/A
  • Country
  • NPV United States
  • CINGW United States
  • Employees
  • NPV N/A
  • CINGW 13
  • Industry
  • NPV Investment Managers
  • CINGW Biotechnology: Pharmaceutical Preparations
  • Sector
  • NPV Finance
  • CINGW Health Care
  • Exchange
  • NPV Nasdaq
  • CINGW Nasdaq
  • Market Cap
  • NPV N/A
  • CINGW N/A
  • IPO Year
  • NPV N/A
  • CINGW 2021
  • Fundamental
  • Price
  • NPV $12.38
  • CINGW $0.04
  • Analyst Decision
  • NPV
  • CINGW
  • Analyst Count
  • NPV 0
  • CINGW 0
  • Target Price
  • NPV N/A
  • CINGW N/A
  • AVG Volume (30 Days)
  • NPV 38.9K
  • CINGW N/A
  • Earning Date
  • NPV 01-01-0001
  • CINGW N/A
  • Dividend Yield
  • NPV 3.90%
  • CINGW N/A
  • EPS Growth
  • NPV N/A
  • CINGW N/A
  • EPS
  • NPV N/A
  • CINGW N/A
  • Revenue
  • NPV N/A
  • CINGW N/A
  • Revenue This Year
  • NPV N/A
  • CINGW N/A
  • Revenue Next Year
  • NPV N/A
  • CINGW N/A
  • P/E Ratio
  • NPV N/A
  • CINGW N/A
  • Revenue Growth
  • NPV N/A
  • CINGW N/A
  • 52 Week Low
  • NPV $8.92
  • CINGW N/A
  • 52 Week High
  • NPV $11.55
  • CINGW N/A
  • Technical
  • Relative Strength Index (RSI)
  • NPV 32.18
  • CINGW N/A
  • Support Level
  • NPV $12.30
  • CINGW N/A
  • Resistance Level
  • NPV $12.41
  • CINGW N/A
  • Average True Range (ATR)
  • NPV 0.11
  • CINGW 0.00
  • MACD
  • NPV -0.02
  • CINGW 0.00
  • Stochastic Oscillator
  • NPV 40.98
  • CINGW 0.00

About CINGW Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Share on Social Networks: